Robert Bain Thomas, Director at REVA Medical, Inc. (RVA.AX), bought 5,000 shares at $3.02 ($15K) on 2018-03-27, disclosed to the SEC on 2018-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA | BUY | 2016-07-19 | $224K | — | Filing → |